References
- Prince D, Petersson D, Steiner R, Gottlied J, Scott R, Israel H, Figueroa W, Fish J. Infections with mycobacterium avium complex in patients without predisposing conditions. N Engl J Med 1989; 321: 863–868
- Heurlin N, Petrini B. Treatment of non-tuberculous mycobacterial infections in patients without AIDS. Scand J Infect Dis 1993; 25: 619–623
- Heurlin N, Andersson J, Bergström S-E, Christensson M, Christensson B. Granulocytosis and lack of Th1 cytokine production in BAL fluid from patients with pulmonary nontuberculous mycobacteriosis. Eur Respir J, accepted
- Sander B, Skansén-Saphir U, Damm O, Håkansson J, Andersson J, Andersson U. Sequential production of Th1 and Th2 cytokines in response to live bacillus Calmettes-Guérin. Immunology 1995; 423: 1–7
- Murray H. Interferon-gamma, the activated macrophage, and host defense against microbial challenge. Ann Int Med 1988; 108: 595–608
- Holland S, Eisenstein E, Kuhns D, Turner M, Fleisher T, Strober W, Gallin J. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. N Engl J Med 1994; 330: 1348–55
- Rose R, Fuglestad J, Remington L. Growth inhibition of Mycobacterium avium complex in human alveolar macrophages by the combination of recombinant macrophage colony-stimulating factor and interferon-gamma. Am J Respir Cell Mol Biol 1991; 4: 248–254
- Bermudes L, Martinelli J, Petrofsky M, Kolonoski P, Young L. Recombinant granulocyte-macrophage colony-stimulating factor enhances the effects of antibiotics against Mycobacterium avium complex infection in beige mouse. J Infect Dis 1994; 169: 575–580
- Shurr E, Malo D, Radzioch D, Bushman E, Morgan K, Gros P, Skamene E. Genetic control of innate resistance to mycobacterial infections. Immunol Today 1991; 12: A42–45
- Williams A, Chanock S, Flanders K. Transforming growth factor-beta (TGF-β) isoforms in tuberculoid and lepromatous leprosy: Immunohistochemical studies. Cell Vision 1995; 2: 363–372